PT - JOURNAL ARTICLE AU - James, Ananthu AU - Dalal, Jyoti AU - Kousi, Timokleia AU - Vivacqua, Daniela AU - Portela Câmara, Daniel Cardoso AU - dos Reis, Izabel Cristina AU - Botero-Mesa, Sara AU - Ng’ambi, Wingston AU - Ansobi, Papy AU - Stoll, Beat AU - Chimbetete, Cleophas AU - Mboussou, Franck AU - Impouma, Benido AU - Hofer, Cristina Barroso AU - Coelho, Flávio Codeço AU - Keiser, Olivia AU - Abbate, Jessica L TI - An in-depth statistical analysis of the COVID-19 pandemic’s initial spread in the WHO African region AID - 10.1101/2021.08.21.21262401 DP - 2021 Jan 01 TA - medRxiv PG - 2021.08.21.21262401 4099 - http://medrxiv.org/content/early/2021/12/29/2021.08.21.21262401.short 4100 - http://medrxiv.org/content/early/2021/12/29/2021.08.21.21262401.full AB - During the first wave of the COVID-19 pandemic, sub-Saharan African countries experienced comparatively lower rates of SARS-CoV-2 infections and related deaths than in other parts of the world, the reasons for which remain unclear. Yet, there was also considerable variation between countries. Here, we explored potential drivers of this variation among 46 of the 47 World Health Organization African region member states in a cross-sectional study. We described five indicators of early COVID-19 spread and severity for each country as of 29 November 2020: delay in detection of the first case, length of the early epidemic growth period, cumulative and peak attack rates, and crude case fatality ratio (CFR). We tested the influence of 13 pre-pandemic and pandemic response predictor variables on the country-level variation in the spread and severity indicators using multivariate statistics and regression analysis. We found that wealthier African countries, with larger tourism industries and older populations, had higher peak (p < 0.001) and cumulative (p < 0.001) attack rates, and lower CFRs (p = 0.021). More urbanized countries also had higher attack rates (p < 0.001 for both indicators). Countries applying more stringent early control policies experienced greater delay in detection of the first case (p < 0.001), but the initial propagation of the virus was slower in relatively wealthy, touristic African countries (p = 0.023). Careful and early implementation of strict government policies were likely pivotal to delaying the initial phase of the pandemic, but did not have much impact on other indicators of spread and severity. An over-reliance on disruptive containment measures in more resource-limited contexts is neither effective nor sustainable. We thus urge decision-makers to prioritize the reduction of resource-based health disparities, and surveillance and response capacities in particular, to ensure global resilience against future threats to public health and economic stability.What is already known on this topic?COVID-19 trajectories varied widely across the world, and within the African continent.There is significant heterogeneity in the surveillance and response capacities among WHO African region member states.What are the new findings?Cumulative and peak attack rates during the first wave of COVID-19 were higher in WHO African region member states with higher per-capita GDP, larger tourism industries, older and more urbanized populations, and higher pandemic preparedness scores.Although better-resourced African countries documented higher attack rates, they succeeded in limiting rapid early spread and mortalities due to COVID-19 infection.African countries that had more stringent early COVID-19 response policies managed to delay the onset of the outbreak at the national level. However, this phenomenon is partially explained by a lack of detection capacity, captured in low pandemic preparedness scores, and subsequent initial epidemic growth rates were slower in relatively well-resourced countries.What do the new findings imply?Careful implementation of strict government policies can aid in delaying an epidemic, but investments in public health infrastructure and pandemic preparedness are needed to better mitigate its impact on the population as a whole.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Swiss National Science Foundation (grants no. 196270 and 163878).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Publicly available COVID-19 data was used in this study, and therefore, no ethical approval was needed. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCOVID-19 data used in this manuscript is available at https://github.com/JyotiDalal93/COVID-19_SSA/blob/main/Data_sub_saharan_Africa.zip. Moreover, data dictionaries, statistical code etc., that support the findings of this study are available upon reasonable request from the corresponding author. https://github.com/JyotiDalal93/COVID-19_SSA/blob/main/Data_sub_saharan_Africa.zip